Graded review
Concierge vs Membership Longevity: What You Actually Get
Concierge clinics ($8k–$25k/yr) sell diagnostics; membership programs ($99–$300/mo) sell ongoing treatment. What each delivers, and where the money goes.
Evidence scorecard
Two providers both call themselves "longevity medicine." One charges $19,000 a year, scans your whole body in an MRI tube, sequences your genome, and assigns you a concierge physician. The other charges $149 a month, mails you a lab kit, and prescribes peptides or hormones over a video call. The price gap is roughly tenfold — and most of what you're actually buying is different in kind, not degree.
This is the comparison that matters most once you've decided you want hands-on longevity care rather than a DTC lab that tests but doesn't treat. The honest framing: a concierge clinic sells you diagnostics; a membership program sells you ongoing treatment. Both can be worth it. Neither has been shown to extend human lifespan. Here is what your money actually buys in each model, and how to decide.
The two models side by side
| | Concierge diagnostic clinic | Membership longevity program | |---|---|---| | Price (2026) | $8,000–$25,000/yr | $99–$300/mo (~$1,200–$3,600/yr) | | Examples | Fountain Life, Human Longevity, Cenegenics | Lifeforce, Next Health, Healthspan, CoreAge Rx | | Core product | Imaging + genomics + MD concierge | Recurring labs + clinician + prescribed therapies | | Delivery | In-person, high-touch | Telehealth + mailed lab kits (mostly) | | What it's best at | Deep one-time diagnostic picture | Longitudinal treatment + retesting | | The honest catch | Over-screening risk; bolt-on unproven therapies | "Healthspan" framing; supplement/vertical-pharmacy upsells |
The single distinction to carry through everything below: does the price buy you a picture, or a plan? Concierge buys the picture — the most detailed scan of your body a consumer can get. Membership buys the plan — a clinician who prescribes, a retesting cadence, and someone watching the numbers over time. The mistake people make is paying concierge prices expecting a plan, or membership prices expecting concierge-grade imaging.
Model Comparison
| Concierge clinic | Membership program | |
|---|---|---|
| Price (2026) | $8,000–$25,000/yr | $99–$300/mo (~$1,200–$3,600/yr) |
| Examples | Fountain Life, Human Longevity, Cenegenics | Lifeforce, Next Health, Healthspan, CoreAge Rx |
| Core product | Whole-body MRI, coronary CT, genomics, in-person MD | Recurring labs + prescribing clinician + retesting + therapies |
| What it is best at | Deep one-time diagnostic picture | Longitudinal treatment and monitoring at an accessible price |
| Honest catch | Over-screening risk; bolt-on unproven therapies | "Healthspan" framing; GH red flag; vertical-pharmacy conflicts |
What a concierge clinic actually delivers
Fountain Life, Human Longevity (Health Nucleus), and Cenegenics define this band. The product is diagnostics you genuinely cannot get elsewhere as a consumer: whole-body and brain MRI, coronary CT angiography with AI plaque analysis, whole-genome sequencing, 100+ biomarker panels, and a physician who quarterbacks all of it in person. Fountain Life's flagship runs about $19,500/yr; Human Longevity's concierge tier reaches roughly $19,000/yr; Cenegenics programs land around $14,000–$21,000/yr once you add the assessment and monthly fees.
What you're really paying for: the depth and the imaging. For some people, a scan catches something genuinely important early — and that is the legitimate case for the model.
The honest catch — over-screening: intensive scanning of asymptomatic people is a double-edged sword, and the data are now specific. A 2026 systematic review and meta-analysis of whole-body MRI across more than 9,000 asymptomatic individuals found a confirmed-cancer detection rate of just 1.57%, alongside frequent incidental findings, unstandardized protocols, and no long-term outcome or cost-effectiveness data — concluding the scans "may lead to unnecessary investigations"1. In plain terms: the imaging that anchors the concierge pitch finds real cancer in about 1 in 64 healthy people, while flagging far more ambiguous spots that drive anxiety, follow-up procedures, and cost. That's not a reason to never scan; it's a reason to treat "early detection" marketing with the skepticism the evidence warrants.
The second concierge catch is the bolt-on. Several clinics in this band attach interventions — plasma exchange, EBOO, NAD+, peptides, growth-hormone secretagogues — to the diagnostic core. Treat the imaging and genomics as the real product and the "reverse aging" add-ons as unproven; we trace the evidence gaps in longevity medicine: what's proven vs hyped.
What a membership program actually delivers
Lifeforce, Next Health, Healthspan, and where CoreAge Rx sits define this band. The model is recurring: a structured panel of 40–100 biomarkers, scheduled retesting every few months, a clinician who reviews results and prescribes, and a menu of therapies — hormone optimization, peptides, GLP-1s, NAD+. Lifeforce runs about $149/mo after a $549 diagnostic; Next Health tiers from roughly $99 to $399/mo. The whole thing usually happens over telehealth with mailed lab kits, which is why it costs a fraction of the concierge model.
What you're really paying for: the thing a DTC lab won't give you and a one-time concierge scan can't — a clinician who can actually prescribe, plus a retesting cadence that lets you see whether an intervention moved your numbers. This is the only band built for longitudinal treatment at an accessible price.
The honest catch — the claims and the conflicts: this band leans hardest on the word "healthspan," and much of what it prescribes — NAD+, peptides, rapamycin — has mechanistic plausibility but no completed human longevity RCT. Two specific things to vet. First, vertical-pharmacy conflict: some membership brands dispense through their own pharmacy, meaning the company recommending a therapy also profits from selling it. Second, the growth-hormone red flag: any program marketing GH or GH-secretagogue peptides as anti-aging is ignoring the evidence — a landmark systematic review of growth hormone in healthy older adults found small body-composition changes but no proven functional benefit and significantly more adverse events2. A good membership provider distinguishes proven from plausible and discloses its conflicts; that honesty is exactly what we grade in are longevity clinics worth it?, and it's the heaviest-weighted axis in how we grade longevity providers.
Where the evidence stands across both models
It's worth stating plainly, because the marketing in both bands blurs it: no intervention sold by either a concierge clinic or a membership program has been shown in a completed randomized trial to extend human lifespan. The strongest human outcome data in the entire field belongs to GLP-1 receptor agonists — the SELECT trial showed semaglutide cut major cardiovascular events by about 20% in overweight and obese adults without diabetes3 — and even that proves cardiovascular risk reduction, not slowed aging. The deeper reason both models operate ahead of their proof: the methodology to run true human healthspan trials is only now maturing, so validated aging endpoints barely exist yet4. A concierge clinic and a $149/mo membership are, at bottom, both selling care in a field where the outcome trials haven't read out.
That shared baseline is liberating, because it collapses the decision to something practical: since neither model can promise a longer life, you're choosing between the best diagnostic picture and the best ongoing treatment relationship — not between "more proven" and "less proven."
Which one is for you?
- Choose concierge if you want the deepest one-time diagnostic picture, money is genuinely no object, and you'll go in clear-eyed about over-screening. Pay for the imaging and genomics; ignore the bolt-on "reverse aging" interventions.
- Choose membership if you want ongoing, prescribed care with retesting and a clinician you can actually reach — at a price that doesn't require a five-figure budget. This is the band that treats. Vet it for vertical-pharmacy conflict and for honesty about what's proven.
- Consider both, sequenced, if budget allows: a one-time concierge or DTC diagnostic snapshot for breadth, then a membership program for the longitudinal treatment a scan can't provide. What you should never do is pay concierge prices for membership-grade therapy — the imaging is the only thing the premium reliably buys.
A physician-overseen peptide/NAD+/GLP-1 telehealth membership sits squarely in the membership band's value lane: more clinically active than a DTC lab, more longevity-focused than an influencer TRT brand, and a fraction of concierge pricing — real oversight without the $20k diagnostic tax. For our independently graded shortlist across every band, with the conflicts and unproven claims flagged, see our longevity provider rankings. For a full breakdown of what every tier costs — from ~$200/yr lab memberships to $20k+ concierge programs — see how much does a longevity clinic cost?.
Frequently asked questions
What's the difference between a concierge longevity clinic and a membership program?
A concierge clinic ($8k–$25k/yr — Fountain Life, Human Longevity, Cenegenics) sells diagnostics: whole-body MRI, coronary CT, genomics, and a physician to interpret them, usually in person. A membership program ($99–$300/mo — Lifeforce, Next Health, CoreAge Rx) sells ongoing treatment: recurring labs, a prescribing clinician, scheduled retesting, and therapies like peptides, hormones, or GLP-1s, mostly over telehealth. The clinic buys you a one-time picture; the membership buys you an ongoing plan.
Is a $20,000 concierge longevity clinic worth it over a $149/month membership?
Only for the diagnostics. The concierge price buys imaging and genomics you can't get from a telehealth membership. But the intensive screening of healthy people carries real over-diagnosis risk — a 2026 meta-analysis of whole-body MRI in over 9,000 asymptomatic adults found just a 1.57% cancer-detection rate alongside frequent incidental findings that may trigger unnecessary investigations — and the interventions clinics bolt on often have no human outcome data. You should never pay concierge prices for therapies a membership delivers more cheaply.
Do membership longevity programs actually prescribe treatment?
Yes — that's the defining feature of the band. Unlike DTC lab memberships that test and hand you off, a membership program assigns a clinician who reviews your labs, prescribes therapies (hormones, peptides, GLP-1s, NAD+), and retests on a schedule so you can see whether an intervention moved your numbers. The honest caveat: vet for vertical-pharmacy conflicts and for honesty about which therapies have human evidence.
Has either model been proven to extend lifespan?
No. Nothing sold by a concierge clinic or a membership program has been shown in a completed randomized trial to extend human lifespan. The strongest human outcome data belongs to GLP-1 drugs (the SELECT trial showed semaglutide cut cardiovascular events about 20%), and even that proves cardiovascular risk reduction, not slowed aging. Both models operate ahead of the evidence, because validated human healthspan trials are only now maturing.
Should I use a concierge clinic or a membership program first?
If budget allows, a one-time diagnostic snapshot (concierge or a cheaper DTC lab panel) for breadth, then a membership program for the longitudinal treatment a single scan can't provide, is the most useful real-world sequence. If you have to pick one, choose based on what you need: the deepest picture (concierge) or ongoing prescribed care at an accessible price (membership).
References
- Martins da Fonseca J, Trennepohl T, Pinheiro LG, et al. (2026). Whole-body MRI for opportunistic cancer detection in asymptomatic individuals: a systematic review and meta-analysis. European Radiology. https://doi.org/10.1007/s00330-025-11976-5
- Liu H, Bravata DM, Olkin I, et al. (2007). Systematic review: the safety and efficacy of growth hormone in the healthy elderly. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-146-2-200701160-00005
- Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. (2023). Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. New England Journal of Medicine. https://doi.org/10.1056/NEJMoa2307563
- Justice JN, Niedernhofer L, Robbins PD, et al. (2018). Development of Clinical Trials to Extend Healthy Lifespan. Cardiovascular Endocrinology & Metabolism. https://doi.org/10.1097/XCE.0000000000000159
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.
More graded reviews
Longevity Medicine: What's Proven vs Hyped
An honest, evidence-graded tour of the longevity toolkit — what has human outcome RCTs versus what is animal or mechanistic-only.
ReadDo NAD+ and Peptides Actually Extend Lifespan?
NAD+ precursors reliably raise NAD+ but show modest, mixed human outcomes. Peptides and growth hormone carry real cautions. An honest evidence review.
ReadRapamycin & Metformin for Longevity: The Evidence
Strong animal data, a glaring human RCT gap. What the PEARL pilot, the TAME rationale, and metformin's observational signal really show.
ReadAre Longevity Clinics Worth It?
DTC and IV longevity clinics sit on the weakest evidence in the field. What a critical review found, and how to vet a provider before paying.
ReadRapamycin for Longevity: Hype vs Evidence
Rapamycin is the most reproducible lifespan extender in mice — but there is no human longevity trial. An honest split of the hype from the evidence.
ReadWhat the PEARL Trial Actually Showed About Rapamycin
PEARL was the largest decentralized RCT of rapamycin in healthy aging — and it missed its primary endpoint. An honest readout of what it did and didn't prove.
ReadLongevity Clinics vs Lab Memberships vs Rx Telehealth: What Each Delivers
The longevity market splits into four bands: concierge clinics, membership programs, DTC labs, single-product Rx. What each delivers, and who it's for.
ReadBiological Age Tests: Do Epigenetic Clocks Actually Work?
Epigenetic clocks (Horvath, GrimAge, DunedinPACE) predict aging well in populations — but are noisy and unproven for individuals. An honest evidence review.
ReadNAD+ for Longevity: What the Trials Actually Show
NR and NMN reliably raise NAD+ in humans, but the trials mostly fail to show clinical or longevity outcomes. An honest review of the hype versus the data.
ReadWhat Do Longevity Biomarker Panels Actually Test?
Longevity panels mix genuinely useful, outcome-validated markers (ApoB, HbA1c, hs-CRP) with vanity numbers. An honest, evidence-graded breakdown.
ReadGLP-1s for Healthspan & Longevity: The Evidence
GLP-1 drugs have the strongest human outcome data in longevity — but it's cardiometabolic risk reduction, not proven lifespan extension. An honest review.
ReadPeptides for Longevity: What's Real and What's Marketing
Most longevity peptides are sold on mechanism and anecdote, not human outcomes. An honest, citation-backed review of what the evidence actually supports.
ReadMetformin for Longevity: The TAME Trial Evidence
Metformin's anti-aging case is mechanistic and observational — no completed RCT proves it. Why the TAME trial exists, and the exercise caveat.
ReadHow We Grade Longevity Providers: Our Methodology
The five-axis rubric behind our longevity provider rankings: oversight, evidence honesty, transparency, price, and conflicts of interest.
ReadBest Longevity Supplements, Rated by Evidence (2026)
We grade the popular longevity supplements — NMN, NR, spermidine, resveratrol, CoQ10, omega-3, vitamin D, fisetin, GlyNAC — on human evidence, not hype.
ReadWhat Is a Longevity Doctor (and Do You Need One)?
A longevity doctor blends preventive medicine, biomarker testing, and lifestyle coaching. What they really do, credentials to check, and who needs one.
ReadSpermidine for Longevity: What the Evidence Shows
Spermidine induces autophagy and dietary intake tracks with lower mortality — but the best human trial was negative. An honest, evidence-graded review.
ReadThe Sitting-Rising Test & Longevity: What the Evidence Actually Shows
The sitting-rising and sit-to-stand tests predict mortality in research — but they're markers of strength, balance, and flexibility, not a verdict.
ReadHow Much Does a Longevity Clinic Cost?
Longevity care runs from ~$200/yr lab memberships to $20k+ concierge programs. A 2026 price-band guide to what each tier buys — and what's worth paying for.
ReadFree Biological-Age Tests & Calculators: Do They Actually Work?
Free biological-age calculators range from validated (PhenoAge from a basic blood panel) to entertainment. An honest guide to what's worth your time.
ReadTaurine for Longevity: Does the 2023 Science Study Hold Up?
A 2023 Science paper called taurine deficiency a driver of aging. A 2025 Science follow-up questioned its core premise. An honest, evidence-graded review.
ReadUrolithin A (Mitopure): Mitochondrial Hype or Real?
Urolithin A (Mitopure) has the cleanest human-trial record of any mitochondrial supplement — modest muscle gains in RCTs. But healthspan isn't lifespan.
ReadFisetin as a Senolytic: What "Hit-and-Run" Dosing Shows
Fisetin was the standout senolytic flavonoid in mouse screens and extended lifespan ~10%. In humans, the longevity data are essentially zero. An honest review.
ReadGlyNAC (Glycine + NAC) for Aging: What the Baylor Trials Actually Show
Baylor RCTs report GlyNAC corrects glutathione deficiency and several aging hallmarks in older adults. But the trials are small and the headlines overstate it.
ReadAlpha-Ketoglutarate (Rejuvant/AKG): Does the "8 Years Younger" Claim Hold Up?
The viral "8 years younger" AKG result came from a 42-person study with no placebo group and an unvalidated aging clock. An honest evidence review.
ReadDasatinib + Quercetin: How Far Along Is the Flagship Senolytic?
Dasatinib + quercetin is the first-in-human senolytic — with small IPF and kidney signals. But it's a chemo drug plus a flavonoid, with no longevity RCT yet.
ReadTruDiagnostic TruAge Review: Is the $229 Epigenetic Clock Worth It?
TruDiagnostic's TruAge uses the well-validated DunedinPACE clock — but no test proves the score predicts YOUR outcomes. An honest, evidence-graded review.
ReadFunction Health Review: Are 100+ Biomarkers Worth $499/yr?
Function Health's 100+ lab membership surfaces real outcome-validated markers — but roughly half are basic labs, and it tests without treating. Honest review.
ReadBryan Johnson's Blueprint Review: Evidence vs N-of-1 Hype
Bryan Johnson's Blueprint is a single-subject experiment with no control group — and roughly 90% of its likely benefit is replicable diet, sleep, and exercise.
ReadVO2 Max and Longevity: The Strongest Fitness Predictor of Lifespan
Cardiorespiratory fitness is one of the best-validated predictors of mortality — low fitness carries risk on par with smoking, and it's trainable.
ReadGrip Strength as a Longevity Biomarker: What the Evidence Shows
In the 140,000-person PURE study, grip strength outpredicted systolic blood pressure for mortality. A genuinely strong, free, at-home biomarker.
ReadFasting-Mimicking Diet (ProLon) Review: Does the Evidence Hold Up?
ProLon's 5-day fasting-mimicking diet has real human trials behind it — but most are tied to its inventor's company. An honest, graded look.
ReadHyperbaric Oxygen for Aging: Does the Telomere Claim Hold Up?
One small Israeli trial reported HBOT lengthened telomeres 38% and cut senescent cells. It's striking, unreplicated, and expensive. An honest, graded review.
ReadCreatine for Aging: The Cheapest Evidence-Backed Supplement?
Creatine has the strongest human evidence of any longevity supplement — for healthspan, not lifespan. With resistance training it adds muscle and strength.
ReadThe Hallmarks of Aging, Explained (and Why They Matter)
The hallmarks of aging are the cellular processes that drive getting old. A plain-English guide to the 2013 and 2023 framework — and why each one gets targeted.
ReadSulforaphane for Longevity: Promising Biology, Preclinical Proof
Sulforaphane from broccoli extends lifespan in worms and activates Nrf2 — but the human longevity evidence is preclinical. An honest, evidence-graded review.
ReadGlycine for Longevity: The Other Half of GlyNAC
Glycine alone extended mouse lifespan ~6% in the ITP. But the dramatic 'reverses aging' results belong to the GlyNAC combo, not solo glycine. An honest review.
ReadMicrodose Lithium for Longevity & Brain Aging: The Evidence
A 2025 Nature study tied lithium deficiency to Alzheimer's in mice. But that's mouse healthspan, not human lifespan — and lithium has a narrow safety window.
ReadErgothioneine: The "Longevity Vitamin"? An Evidence-Graded Review
Ergothioneine has a strong observational link to lower mortality — but no human trial, and the signal may just track a healthy diet. An honest grade.
ReadOmega-3 for Longevity: What the DO-HEALTH Trial Actually Shows
DO-HEALTH found 1 g/day omega-3 slowed epigenetic clocks by ~3–4 months. Real, randomized — but a small, surrogate effect. An honest evidence grade.
ReadCoQ10 & Ubiquinol for Aging: What the Evidence Actually Shows
KiSel-10 showed CoQ10 plus selenium cut cardiovascular mortality in elderly Swedes — but the benefit is CV-specific, not lifespan. An honest grade.
ReadBest Epigenetic Clock: GrimAge vs PhenoAge vs DunedinPACE
GrimAge predicts mortality, PhenoAge predicts disease, DunedinPACE measures pace of aging. No clock is validated to guide your treatment. An honest comparison.
ReadGlycanAge Review: Is the Glycan Aging Test Worth It?
GlycanAge measures IgG glycans tied to inflammation, and they move with lifestyle — but independent validation is thin and it can't localize a problem. Graded.
ReadGalleri Multi-Cancer Test Review: Is It Worth It?
Galleri's blood test can flag a cancer signal across many types — but no trial shows it saves lives, and false positives trigger costly cascades. Graded.
ReadFountain Life vs Human Longevity Inc: MRI Clinics Compared
Two whole-body-MRI longevity clinics compared. The headline isn't the price — it's the incidentaloma problem: most scary scan findings turn out to be nothing.
ReadSauna & Longevity: What the Finnish Studies Actually Show
Frequent sauna use is tied to ~40% lower all-cause mortality in Finnish men — but it's one observational cohort, not a randomized trial. An honest grade-B read.
ReadCold Plunge for Longevity: Hype vs Evidence
Cold exposure extends lifespan in worms and flies — but there's zero human lifespan data, and the human evidence is about recovery and mood, not living longer.
ReadZone 2 Training for Longevity: The Evidence, Graded Honestly
Zone 2 has a strong mitochondrial mechanism and builds the fitness that predicts lifespan — but no trial proves Zone 2 itself extends life. Graded honestly.
ReadOutlive by Peter Attia: An Evidence-Based Review
Attia's Outlive popularized Medicine 3.0 and the Four Horsemen. We grade the framework honestly: where the evidence is strong, and where it's reasoned opinion.
ReadBest Longevity Blood Test Services, Compared (2026)
Function, InsideTracker, Lifeforce, Superpower — graded honestly. The four cheap outcome-validated markers matter; the '100+ biomarker' count mostly doesn't.
ReadBest At-Home Biological Age Test (2026): Honestly Graded
Blood-methylation clocks are the only defensible at-home bio-age tier; saliva and telomere kits are noisier. None proves you're aging slower. Honestly graded.
ReadInsideTracker Review: Worth It in 2026?
InsideTracker adds DNA and an 'InnerAge' score to blood panels. The core markers are real, but it's pricier per marker and recommendations skew to upsells.
ReadLifeforce Review: Is the Membership Worth It?
Lifeforce bundles a clinician and Rx onto a ~50-marker quarterly panel for ~$129/mo. That crosses test-into-treat — but the panel is narrow and the upsell real.
ReadDoes Resveratrol Actually Work for Longevity?
A skeptical, evidence-graded review: the SIRT1 story was an artifact, a 2025 primate trial found no lifespan benefit, and oral resveratrol barely reaches cells.
ReadCollagen for Aging: What the Evidence Says
Industry-funded trials show skin and joint benefits; independent reviews are cautious. Collagen digests to amino acids, and the longevity claim is unproven.
ReadQuercetin for Longevity: Senolytic Hype vs Evidence
Quercetin's senolytic effect needs the dasatinib combination. Standalone quercetin has no human senolytic evidence — just modest anti-inflammatory effects.
ReadSuperpower Health Review: Is the $499 100-Lab Membership Worth It?
Superpower's $499/yr 100+ lab membership is slick and cheap-per-marker — but it tests without treating, and the panel leans on padding. Honest, graded review.
ReadFunction Health vs Superpower: Which Lab Membership Wins?
Function Health vs Superpower, graded honestly: nearly identical 100+ lab memberships that both test without treating. The tiebreaker isn't the marker count.
ReadNOVOS Core Review: Does the 12-Ingredient Longevity Drink Work?
NOVOS Core bundles 12 longevity ingredients into one daily drink. The formulation logic is real; the human lifespan proof isn't. An honest, graded review.
ReadTally Health Review: Is the TruAge Epigenetic Membership Worth It?
Tally Health pairs a TruAge epigenetic-age test with coaching and a supplement. The clock is real science; tracking your own aging with it isn't proven.
ReadNOVOS vs Tally Health: Which Longevity Brand Is Worth It?
NOVOS sells a multi-pathway longevity supplement; Tally Health sells an epigenetic-age test plus its own pill. A graded, honest head-to-head on what's proven.
ReadSpermidine vs Fisetin: Two Longevity Supplements, Honestly Compared
Spermidine targets autophagy; fisetin clears senescent cells. Different mechanisms, different evidence grades — an honest, head-to-head longevity comparison.
ReadFunction Health vs InsideTracker: Which Lab-Test Membership Wins?
Function casts a wide 100+ marker net; InsideTracker pairs fewer markers with an algorithm. We grade breadth, actionability, price — and who each fits.
ReadGlycine vs GlyNAC: Is Adding NAC Worth It for Longevity?
GlyNAC adds N-acetylcysteine to glycine for glutathione restoration. Is the extra ingredient worth it for longevity? An honest, graded comparison.
ReadAcarbose for Longevity: The Strongest Mouse Drug You've Never Heard Of
Acarbose robustly extended mouse lifespan in the NIA's rigorous ITP — better replicated than most longevity drugs. But there are zero human longevity trials.
ReadIntermittent Fasting for Longevity: What the Human Trials Actually Show
Time-restricted eating and 5:2 have strong animal data — but human trials show the benefit is mostly about eating less, not the clock. No lifespan proof.
ReadBerberine for Longevity: Nature's Metformin, or Marketing?
Berberine activates AMPK like metformin and lowers glucose and lipids in humans — but its longevity evidence is animal-only. An honest look at the hype.
Read